ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1186

The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients

Cristián Vera-Kellet Sr., Pablo del Barrio-Díaz Sr., Jorge Manríquez-Moreno Sr. and Carlos Reyes-Vivanco Sr., Dermatology, Pontificia Universidad Católica de Chile, Santiago, Chile

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cutaneous lupus erythematosus, Cutaneous manifestations, dermatomyositis and oral, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Epidemiology and Public Health - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There are few studies comparing oral manifestations in patients with Cutaneous Lupus (CL), Systemic Lupus Erythematosus (SLE) and Dermatomyositis (DM). Our objective was to determine signs in the oral cavity that could allow us to guide a particular diagnosis

Methods: Two dermatologists described the semiological findings of photographs of the oral cavity of a total of 116 patients (96 patients with Lupus and 20 patients with DM). All patients with SLE fulfilled at least 4 ACR classification criteria. We analyzed 4 areas: gums, soft palate, hard palate and buccal mucosa. For each of these areas the evaluators described the presence of the following clinical findings: red macules, red dots, telangiectasias, pigmented light brown macules, pigmented dark brown macules, discoid lesions, whitish streaks, white patches, mucosal folds, fine cobblestone and thick cobblestone (Fig. 1, 2, 3). We tried to find mucosal clinical features that differentiate patients with strictly CL with those with CL and SLE, and with those with strictly SLE. Also we compared oral features of patients with SLE (with or without skin involvement) of those with DM, since sometimes these 2 clinical entities are very similar. Patients were divided into 3 different groups: SLE with and without cutaneous involvement; CL with and without systemic manifestations and subjects with DM and SLE with or without cutaneous manifestations. X2 or Fisher exact test was used. A p value < 0.05 was considered significant

Results: Of all 84 patients with CL (with or without SLE), discoid mucous patches were only seen in patients with CL with SLE (15.4% vs 0%, p=0.008). Light and dark brown macules on gums were more frequent in patients with CL without SLE (48.3% vs 23.1% p=0.033 and 27.6% vs 7.7% p=0.033, respectively). Of all 38 SLE patients (with or without CL), red spots on hard palate and thick cobblestone on gums were more common in patients with SLE with CL (69.2% vs 33.3% p=0.037 and 53.8% vs 16.7 % p=0.031, respectively). White mucous streaks were more frequent in patients with SLE without CL (41.7% vs 3.8%, p=0.008). When comparing 38 SLE patients and 20 patients with DM, the mucosal folds on hard palate were only in SLE patients (15.8% vs 0%, p=0.084)

Conclusion: There are signs in the oral cavity that help us to differentiate CL from SLE, and SLE from DM Fig 1: white patch Fig 2: discoid lesion Fig 3: fine cobblestone


Disclosure: C. Vera-Kellet Sr., None; P. del Barrio-Díaz Sr., None; J. Manríquez-Moreno Sr., None; C. Reyes-Vivanco Sr., None.

To cite this abstract in AMA style:

Vera-Kellet C Sr., del Barrio-Díaz P Sr., Manríquez-Moreno J Sr., Reyes-Vivanco C Sr.. The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-use-of-clinical-mucosal-manifestations-to-differentiate-patients-with-lupus-and-dermatomyositis-transversal-retrospective-and-analytical-study-of-116-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-use-of-clinical-mucosal-manifestations-to-differentiate-patients-with-lupus-and-dermatomyositis-transversal-retrospective-and-analytical-study-of-116-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology